Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis.
about
Sex steroid hormone metabolism in relation to risk of aggressive prostate cancerPCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experienceSerum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study.Systematic review and meta-analysis of COX-2 expression and polymorphisms in prostate cancer.Circulating steroid hormones in prostate carcinogenesis. Part 2: Estrogens.IL-10 polymorphisms and prostate cancer risk: a meta-analysis.
P2860
Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis.
@en
Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis.
@nl
type
label
Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis.
@en
Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis.
@nl
prefLabel
Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis.
@en
Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis.
@nl
P2093
P2860
P50
P356
P1476
Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis
@en
P2093
Giovanni Blandino
Holger J Schünemann
Kim C Westerlind
Paola Muti
Rossella Lauria
Saverio Stranges
P2860
P2888
P356
10.1186/1756-9966-28-135
P577
2009-10-08T00:00:00Z
P5875
P6179
1042594986